367 related items for PubMed ID: 28158993
21. [Minimal change disease and focal segmental glomerulosclerosis in children--histomorphometric comparative study with application to computer image analysis].
Danilewicz M, Wagrowska-Danilewicz M.
Przegl Lek; 1996; 53(7):529-33. PubMed ID: 8975287
[Abstract] [Full Text] [Related]
22. Urinary soluble HLA class I antigen in patients with minimal change disease: a predictor of steroid response.
Park CW, Song HC, Shin YS, Ahn SJ, Kim YS, Kim SY, Choi EJ, Chang YS, Bang BK.
Nephron; 1998; 79(1):44-9. PubMed ID: 9609461
[Abstract] [Full Text] [Related]
23. Glomerular tip lesion: a distinct entity within the minimal change disease/focal segmental glomerulosclerosis spectrum.
Stokes MB, Markowitz GS, Lin J, Valeri AM, D'Agati VD.
Kidney Int; 2004 May; 65(5):1690-702. PubMed ID: 15086908
[Abstract] [Full Text] [Related]
24. Reduced INF2 expression in nephrotic syndrome is possibly related to clinical severity of steroid resistance in children.
Tamura H, Nakazato H, Kuraoka S, Yoneda K, Takahashi W, Endo F.
Nephrology (Carlton); 2016 Jun; 21(6):467-75. PubMed ID: 26383224
[Abstract] [Full Text] [Related]
25. Synaptopodin immunoexpression in steroid-responsive and steroid-resistant minimal change disease and focal segmental glomerulosclerosis.
Wagrowska-Danilewicz M, Danilewicz M.
Nefrologia; 2007 Jun; 27(6):710-5. PubMed ID: 18336100
[Abstract] [Full Text] [Related]
26. Urinary low-molecular-weight protein excretion in pediatric idiopathic nephrotic syndrome.
Chehade H, Parvex P, Poncet A, Werner D, Mosig D, Cachat F, Girardin E.
Pediatr Nephrol; 2013 Dec; 28(12):2299-306. PubMed ID: 23949592
[Abstract] [Full Text] [Related]
27. Proteomic Analysis of Idiopathic Nephrotic Syndrome Triggered by Primary Podocytopathies in Adults: Regulatory Mechanisms and Diagnostic Implications.
Chen Q, Xu J, Liu L, Ye Q, Lin W, Liao Y, Gao R, Zhang X, Chen R, Xiong Y, Chen S, Ye X, Wei L.
J Proteome Res; 2024 Jun 07; 23(6):2090-2099. PubMed ID: 38728052
[Abstract] [Full Text] [Related]
28. Ultrastructural features and expression of cytoskeleton proteins of podocyte from patients with minimal change disease and focal segmental glomerulosclerosis.
Shi SF, Wang SX, Zhang YK, Zhao MH, Zou WZ.
Ren Fail; 2008 Jun 07; 30(5):477-83. PubMed ID: 18569926
[Abstract] [Full Text] [Related]
29. [Nephrotic syndrome in minimal change disease (kidney), focal segmental glomerulosclerosis, and focal mesangioproliferative glomerulonephritis].
Voznesenskaia TS, Sergeeva TV.
Ter Arkh; 2002 Jun 07; 74(6):31-3. PubMed ID: 12136479
[Abstract] [Full Text] [Related]
30. Any value of podocyte B7-1 as a biomarker in human MCD and FSGS?
Novelli R, Gagliardini E, Ruggiero B, Benigni A, Remuzzi G.
Am J Physiol Renal Physiol; 2016 Mar 01; 310(5):F335-41. PubMed ID: 26697986
[Abstract] [Full Text] [Related]
31. The utility of urinary CD80 as a diagnostic marker in patients with renal diseases.
Minamikawa S, Nozu K, Maeta S, Yamamura T, Nakanishi K, Fujimura J, Horinouchi T, Nagano C, Sakakibara N, Nagase H, Shima H, Noda K, Ninchoji T, Kaito H, Iijima K.
Sci Rep; 2018 Nov 23; 8(1):17322. PubMed ID: 30470792
[Abstract] [Full Text] [Related]
32. In situ evaluation of podocytes in patients with focal segmental glomerulosclerosis and minimal change disease.
da Silva CA, Monteiro MLGDR, Araújo LS, Urzedo MG, Rocha LB, Dos Reis MA, Machado JR.
PLoS One; 2020 Nov 23; 15(11):e0241745. PubMed ID: 33147279
[Abstract] [Full Text] [Related]
33. Distinct urinary lipid profile in children with focal segmental glomerulosclerosis.
Erkan E, Zhao X, Setchell K, Devarajan P.
Pediatr Nephrol; 2016 Apr 23; 31(4):581-8. PubMed ID: 26537928
[Abstract] [Full Text] [Related]
34. Evaluation of C4d expression and staining patterns by immunohistochemistry in renal biopsy samples with focal segmental glomerulosclerosis and minimal change disease.
Abedi M, Nili F, Dehkhoda F, Abdollahi A, Salarvand S.
Ann Diagn Pathol; 2024 Jun 23; 70():152281. PubMed ID: 38417352
[Abstract] [Full Text] [Related]
35. Urinary proteins from patients with nephrotic syndrome alters the signalling proteins regulating epithelial-mesenchymal transition.
Wen Q, Huang Z, Zhou SF, Li XY, Luo N, Yu XQ.
Nephrology (Carlton); 2010 Feb 23; 15(1):63-74. PubMed ID: 20377773
[Abstract] [Full Text] [Related]
36. Increased glomerular and extracellular malondialdehyde levels in patients and rats with focal segmental glomerulosclerosis.
Kuo HT, Kuo MC, Chiu YW, Chang JM, Guh JY, Chen HC.
Eur J Clin Invest; 2005 Apr 23; 35(4):245-50. PubMed ID: 15816993
[Abstract] [Full Text] [Related]
37. Urinary cytokines and steroid responsiveness in idiopathic nephrotic syndrome of childhood.
Woroniecki RP, Shatat IF, Supe K, Du Z, Kaskel FJ.
Am J Nephrol; 2008 Apr 23; 28(1):83-90. PubMed ID: 17914249
[Abstract] [Full Text] [Related]
38. Minimal change disease and idiopathic FSGS: manifestations of the same disease.
Maas RJ, Deegens JK, Smeets B, Moeller MJ, Wetzels JF.
Nat Rev Nephrol; 2016 Dec 23; 12(12):768-776. PubMed ID: 27748392
[Abstract] [Full Text] [Related]
39. Angiopoietin-like-4 and minimal change disease.
Cara-Fuentes G, Segarra A, Silva-Sanchez C, Wang H, Lanaspa MA, Johnson RJ, Garin EH.
PLoS One; 2017 Dec 23; 12(4):e0176198. PubMed ID: 28441404
[Abstract] [Full Text] [Related]
40. Childhood minimal change disease and focal segmental glomerulosclerosis: a continuous spectrum of disease? Pathologic study of 33 cases with long-term follow-up.
Lichtig C, Ben-Izhak O, On A, Levy J, Allon U.
Am J Nephrol; 1991 Dec 23; 11(4):325-31. PubMed ID: 1799192
[Abstract] [Full Text] [Related]
Page: [Previous] [Next] [New Search]
